Global Liver Institute

(Washington, D.C., May 3, 2022) – Global Liver Institute (GLI), a premier patient-led liver health nonprofit operating globally, is deeply concerned by the draft opinion published by POLITICO indicating the Supreme Court of the United States may overturn Roe v. Wade. A decision of this magnitude…

(Washington, D.C., April 29, 2022) – As leaders in the liver cancer community, Global Liver Institute and their Liver Cancers team expresses our gratitude and recognizes Dr. Ned Sharpless and his tremendous work as the Director of the National Cancer Institute (NCI), part of the National Institute…

Today, April 6, the members of the Liver Action Network (LAN) pledge our collective support for Living Donor Day to honor the donors, recipients, families and caregivers, and clinical teams that make the lifesaving gift of organ donation possible globally. In connection with this pledge, the U.S. members…

On November 4th 2021, Global Liver Institute led an Externally Led Patient-Focused Drug Development Meeting on NASH. This GLI led EL-PFDD meeting on NASH provided regulators, and drug developers the invaluable opportunity to hear from patients and caregivers directly about the challenges and burdens of this life-threatening…

Washington, DC – March 7, 2022 – Global Liver Institute (GLI) will convene the fifth International NASH Day (#NASHday) on June 9, 2022 with the theme Stop NASH Now. This year, GLI is pleased to support grassroots efforts from around the globe that will raise awareness and promote diagnosis and care options in ways as unique as each community. Held annually on the second Thursday in June, #NASHDay…

As members of Global Liver Institute’s Liver Action Network (LAN), the undersigned organizations are proud to take part in World Obesity Day, and take action to recognize the bidirectional relationship between many chronic liver diseases like nonalcoholic steatohepatitis (NASH), and obesity. Worldwide, NASH affects more than 148 million people and continues to rise each year.1 Increasing amounts…

(Washington, D.C., March 2, 2022) – Global Liver Institute (GLI) proudly announces the expansion of the Liver Action Network (LAN) to include a partnership with Empire Liver Foundation. Based in New York City, this transformative organization provides clinical training to healthcare professionals on how to screen and treat patients with Hepatitis B & C in a variety of clinical settings. “Empire Liver Foundation…

On Tuesday, February 15, the United States Senate confirmed Dr. Robert Califf to lead the Food and Drug Administration (FDA) in a 50-46 vote. For the last 13 months there has been a critical gap in permanent leadership at the FDA. During this extended break, especially during a global pandemic, we greatly appreciate Acting Commissioner Dr. Janet Woodcock’s guidance and service. However, withou…

WASHINGTON, DC, FEBRUARY 1, 2022 – Global Liver Institute (GLI), a patient-led liver health nonprofit operating globally, is proud to announce today the launch of its second annual Rare Liver Diseases Month as part of its mission to improve the lives of individuals and families impacted by liver disease. The campaign, themed #RareAware, will feature an array of activities throughout February, including…

Washington, DC, January 14, 2022 – In 2021, the Global Liver Institute (GLI) formed the Liver Action Network (LAN) to better synchronize engagement across the liver advocacy community, and to meet the needs of a rapidly growing cadre of liver health advocates. The LAN operates as a first-of-its-kind network that provides community member organizations a central structure for the formulation…